|1.||Yoshikawa, Masaaki: 2 articles (05/2007 - 04/2006)|
|2.||Tsuruki, Takahiro: 2 articles (05/2007 - 04/2006)|
|3.||Takahata, Kyoya: 1 article (05/2007)|
|4.||Oppenheim, Joost J: 1 article (05/2005)|
|5.||Chen, Qian: 1 article (05/2005)|
|6.||Yang, De: 1 article (05/2005)|
|7.||Kurosaka, Kahori: 1 article (05/2005)|
|8.||Yarovinsky, Felix: 1 article (05/2005)|
|9.||Iribarren, Pablo: 1 article (02/2005)|
|10.||Li, Jianxiang: 1 article (02/2005)|
05/01/2007 - "On the other hand, the anti-alopecia effect of MMK-1 was completely abolished by WRW(4). "
04/01/2006 - "The anti-alopecia effect of orally administered MMK-1 was also blocked by an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate, suggesting that the oral anti-alopecia effect of MMK-1 may be mediated by activation of NF-kappaB. "
04/01/2006 - "Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1."
04/01/2006 - "Oral administration for 6 days of 100 mg/kg MMK-1, an agonist peptide selective for the FPRL1 receptor, suppressed alopecia induced by the anticancer drug etoposide in neonatal rats. "
05/01/2007 - "Hence, we suggest that the anti-alopecia mechanisms of intraperitoneally administered fMLP and MMK-1 include activation of NF-kappaB via IL-1 release downstream of the FPRL1 receptor homolog in rats."
|2.||Muscle Cramp (Cramp)
|3.||Alzheimer Disease (Alzheimer's Disease)
02/01/2005 - "Interestingly, the N-terminus and a segment between the fourth transmembrane domain and the third intracellular loop of FPRL1 are important for receptor interaction with a 42 amino acid amyloid beta peptide (Abeta42), an Alzheimer's disease-associated FPRL1 agonist, but not with MMK-1, a synthetic FPRL1 agonist, suggesting that diverse agonists may use different domains in FPRL1. "
|1.||NF-kappa B (NF-kB)
|2.||Etoposide (VP 16)
|3.||human FPR2 protein
|4.||pyrrolidine dithiocarbamic acid
|5.||Formyl Peptide Receptors (Formyl Peptide Receptor)
|8.||Histamine H2 Receptors
|10.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)